Showing results (181-190 of 346) with videos related to
Sort By:
Pageof 35
Bone Marrow Transplantation|December 23, 2017
Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefitBrittany Knick Ragon, Rohtesh S Mehta, Alison M Gulbis, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2015
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological MalignanciesAmin M Alousi, Jonathan E Brammer, Rima M Saliba, et al.Nature Reviews. Clinical Oncology|September 20, 2017
Chimeric antigen receptor T-cell therapy - assessment and management of toxicitiesSattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Sleeping beauty system to redirect T-cell specificity for human applicationsSourindra N Maiti, Helen Huls, Harjeet Singh, et al.Human Gene Therapy|November 13, 2009
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignanciesPallavi V Raja Manuri, Matthew H Wilson, Sourindra N Maiti, et al.Cancer|May 18, 2017
Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myelomaLauren W Veltri, Denái R Milton, Ruby Delgado, et al.Cancer|August 27, 2015
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaFarhad Ravandi, Susan M O'Brien, Jorge E Cortes, et al.Leukemia & Lymphoma|July 9, 2019
Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 yearsQaiser Bashir, Kamal Chamoun, Denái R Milton, et al.Transplantation and Cellular Therapy|March 30, 2021
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host DiseaseRohtesh S Mehta, Rima M Saliba, Anna Jan, et al.Transplantation and Cellular Therapy|May 23, 2021
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid LeukemiaFevzi F Yalniz, Rima M Saliba, Uri Greenbaum, et al.Pageof 35